Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS) | MicrobiomeTrials← Back to trialsNCT03568669
Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
RecruitingOBSERVATIONAL
Trial Details
Start: 2016-01Est. Completion: 2030-12
Enrollment target: 1,000 participants Locations- Children's Hospital Los Angeles, Los Angeles, California, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Seattle Children's Hospital, Seattle, Washington, United States
Other microbiome trials you might be interested in
Congenital Central Hypoventilation Syndrome
The Center for Autonomic Medicine in Pediatrics (CAMP), in collaboration with leading CCHS clinicians, scientists, and p…
Chicago, United StatesEst. completion Dec 31, 2031
Sickle Cell Disease (SCD)Sickle Cell Disease Vaso-occlusive CrisisSickle Cell Anemia CrisisSickle Cell Anemia in ChildrenSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Sickle Cell Hemoglobin C DiseasePain Crisis
The goal of this clinical trial is to learn whether a single dose of buccal buprenorphine (BELBUCA) is safe when used in…
Boston, United StatesEst. completion Oct 2031